UA88156C2 - Комбинации противорвотного средства и ингибитора энкефалиназы для лечения гастроэнтерита и диареи - Google Patents

Комбинации противорвотного средства и ингибитора энкефалиназы для лечения гастроэнтерита и диареи

Info

Publication number
UA88156C2
UA88156C2 UAA200608901A UAA200608901A UA88156C2 UA 88156 C2 UA88156 C2 UA 88156C2 UA A200608901 A UAA200608901 A UA A200608901A UA A200608901 A UAA200608901 A UA A200608901A UA 88156 C2 UA88156 C2 UA 88156C2
Authority
UA
Ukraine
Prior art keywords
combinations
gastroenteritis
treating diarrhea
emetic agent
enkephalinase inhibitor
Prior art date
Application number
UAA200608901A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Жан-Шарль Шварц
Жан-Мари Леконт
Original Assignee
Биопроже
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684783&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA88156(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Биопроже filed Critical Биопроже
Publication of UA88156C2 publication Critical patent/UA88156C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Otolaryngology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
UAA200608901A 2004-02-12 2005-02-14 Комбинации противорвотного средства и ингибитора энкефалиназы для лечения гастроэнтерита и диареи UA88156C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04290384A EP1563848A1 (en) 2004-02-12 2004-02-12 New combinations of an anti-emetic agent and an enkephalinase inhibitor

Publications (1)

Publication Number Publication Date
UA88156C2 true UA88156C2 (ru) 2009-09-25

Family

ID=34684783

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200608901A UA88156C2 (ru) 2004-02-12 2005-02-14 Комбинации противорвотного средства и ингибитора энкефалиназы для лечения гастроэнтерита и диареи

Country Status (28)

Country Link
US (1) US8222294B2 (enExample)
EP (2) EP1563848A1 (enExample)
JP (1) JP4987487B2 (enExample)
KR (1) KR101152308B1 (enExample)
CN (1) CN1917903B (enExample)
AT (1) ATE468138T1 (enExample)
AU (1) AU2005215262B2 (enExample)
BR (1) BRPI0506631B8 (enExample)
CA (1) CA2553827C (enExample)
CY (1) CY1110202T1 (enExample)
DE (1) DE602005021317D1 (enExample)
DK (1) DK1718337T3 (enExample)
EA (1) EA010625B1 (enExample)
EC (1) ECSP066758A (enExample)
ES (1) ES2344909T3 (enExample)
HR (1) HRP20100363T1 (enExample)
MA (1) MA28354A1 (enExample)
ME (1) ME01175B (enExample)
NO (1) NO337320B1 (enExample)
NZ (1) NZ548635A (enExample)
PL (1) PL1718337T3 (enExample)
PT (1) PT1718337E (enExample)
RS (1) RS51329B (enExample)
SI (1) SI1718337T1 (enExample)
TN (1) TNSN06246A1 (enExample)
UA (1) UA88156C2 (enExample)
WO (1) WO2005079850A1 (enExample)
ZA (1) ZA200605872B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900823B1 (fr) * 2006-05-15 2009-02-13 Bioprojet Soc Civ Ile Nouvelle forme d'administration du racecadotril.
EP2462922A1 (en) * 2010-12-10 2012-06-13 Bioprojet New form of administration of enkephalinase inhibitor
EP2866789B1 (en) 2012-06-28 2018-08-01 Johnson & Johnson Consumer Inc. Racecadotril lipid compositions
US9114171B2 (en) * 2012-06-28 2015-08-25 Mcneil-Ppc, Inc. Racecadotril liquid compositions
US9801819B2 (en) * 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
PT2866802T (pt) * 2012-06-28 2016-09-05 Johnson & Johnson Consumer Inc Composições líquidas racecadotril
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins

Also Published As

Publication number Publication date
ATE468138T1 (de) 2010-06-15
CY1110202T1 (el) 2015-01-14
DK1718337T3 (da) 2010-07-26
JP4987487B2 (ja) 2012-07-25
CA2553827C (en) 2012-08-07
SI1718337T1 (sl) 2010-08-31
AU2005215262B2 (en) 2011-03-03
MA28354A1 (fr) 2006-12-01
US8222294B2 (en) 2012-07-17
ECSP066758A (es) 2006-11-24
KR20060132691A (ko) 2006-12-21
BRPI0506631B8 (pt) 2021-05-25
KR101152308B1 (ko) 2012-06-11
CA2553827A1 (en) 2005-09-01
NO20063973L (no) 2006-09-05
EP1718337B1 (en) 2010-05-19
US20070275993A1 (en) 2007-11-29
AU2005215262A1 (en) 2005-09-01
ZA200605872B (en) 2008-01-08
BRPI0506631A (pt) 2007-05-08
EP1718337A1 (en) 2006-11-08
JP2007522202A (ja) 2007-08-09
NO337320B1 (no) 2016-03-07
EA010625B1 (ru) 2008-10-30
PT1718337E (pt) 2010-06-16
DE602005021317D1 (de) 2010-07-01
NZ548635A (en) 2009-10-30
CN1917903A (zh) 2007-02-21
CN1917903B (zh) 2010-07-21
WO2005079850A1 (en) 2005-09-01
ES2344909T3 (es) 2010-09-09
BRPI0506631B1 (pt) 2018-12-04
ME01175B (me) 2013-03-20
EP1563848A1 (en) 2005-08-17
EA200601466A1 (ru) 2006-12-29
RS51329B (sr) 2011-02-28
TNSN06246A1 (fr) 2007-12-03
PL1718337T3 (pl) 2010-09-30
HRP20100363T1 (hr) 2010-07-31

Similar Documents

Publication Publication Date Title
NO20083147L (no) Anti-OX40L-antistoffer og fremgangsmater for anvendelse av disse
WO2008005457A3 (en) Pyridinonyl pdk1 inhibitors
WO2008036410A3 (en) Methods and compositions for treating amyotrophic lateral sclerosis (als)
MX2009009290A (es) Compuestos activos en ppar.
WO2008033408A3 (en) Methods for identifying compounds that modulate cell signaling and methods employing such compounds
WO2006083782A3 (en) Directed differentiation of embryonic stem cells and uses thereof
TW200714283A (en) Method and composition for treating peripheral vascular diseases
TW200626989A (en) Multifocal lenses for pre-presbyopic individuals
PA8660001A1 (es) Amino-imidazolonas para la inhibicion de b-secretasa
NO20090047L (no) Anti-DLL4-antistoffer og fremgangsmater for anvendelse av disse
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
WO2007130697A8 (en) Anti-ephb4 antibodies and methods using same
WO2005044093A3 (en) Delta-9- the treatment of multiple sclerosis
WO2007076174A3 (en) Methods, systems, and apparatus for multi-domain markers
CY1110202T1 (el) Νεοι συνδυασμοι ενος αντι εμετικου παραγοντα και ενος αναστολεα της εγκεφαλινασης
NO20075140L (no) Fremgangsmater og preparater for modulering av vaskulaer integritet
WO2007132355A3 (en) Compositions and methods for inhibiting viral adhesion
FI20031191A7 (fi) Monoamiinin takaisinoton estäjä
TW200621744A (en) Mercaptoamides as histone deacetylase inhibitors
WO2006060774A3 (en) Agents that inhibit flavivirus replication and uses thereof
WO2006018328A3 (de) Kompakthaarspray
WO2007008769A3 (en) Use of pseudan and pseudan inclusion bodies
TW200714284A (en) Novel method
WO2006116687A3 (en) Nanoassays
TW200505468A (en) Agent for improving hepato-bililary dysfunction